NYSEAMERICAN:ISR - IsoRay Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.5070 +0.01 (+2.01 %)
(As of 05/27/2018 03:41 AM ET)
Previous Close$0.5070
Today's Range$0.50 - $0.5120
52-Week Range$0.36 - $0.64
Volume162,667 shs
Average Volume196,575 shs
Market Capitalization$24.87 million
P/E RatioN/A
Dividend YieldN/A
Beta1.22

About IsoRay (NYSEAMERICAN:ISR)

IsoRay logoIsoRay, Inc. is a medical technology company. The Company, through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. The Cs-131 includes radioisotope in the treatment of all malignant tumors, such as prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma and pancreatic cancer. The Company's Proxcelan Cesium-131 seed is classified as a Class II device.

Receive ISR News and Ratings via Email

Sign-up to receive the latest news and ratings for ISR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSEAMERICAN:ISR
CUSIPN/A
Phone+1-509-3751202

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-95.25%
Return on Equity-69.11%
Return on Assets-58.22%

Miscellaneous

EmployeesN/A
Outstanding Shares55,100,000

IsoRay (NYSEAMERICAN:ISR) Frequently Asked Questions

What is IsoRay's stock symbol?

IsoRay trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ISR."

How were IsoRay's earnings last quarter?

IsoRay (NYSEAMERICAN:ISR) announced its quarterly earnings results on Thursday, May, 3rd. The healthcare company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.01. The healthcare company earned $1.57 million during the quarter. IsoRay had a negative return on equity of 69.11% and a negative net margin of 95.25%. View IsoRay's Earnings History.

What price target have analysts set for ISR?

2 analysts have issued 1-year target prices for IsoRay's stock. Their predictions range from $1.00 to $2.00. On average, they anticipate IsoRay's share price to reach $1.50 in the next year. View Analyst Ratings for IsoRay.

Are investors shorting IsoRay?

IsoRay saw a increase in short interest in the month of May. As of May 15th, there was short interest totalling 154,774 shares, an increase of 226.9% from the April 30th total of 47,341 shares. Based on an average daily volume of 571,877 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.3% of the shares of the company are short sold.

Who are IsoRay's key executives?

IsoRay's management team includes the folowing people:
  • Thomas C. LaVoy, Chairman of the Board, Chief Executive Officer
  • Mark John Austin, Principal Financial Officer, Principal Accounting Officer, Controller
  • William Cavanagh III, Chief Operating, Scientific Officer
  • Michael Krachon, Vice President of Sales and Marketing
  • Jennifer Streeter, Vice President - Human Resources
  • Alan Hoffmann, Independent Director
  • Michael W. McCormick, Independent Director
  • Philip J. Vitale M.D., Independent Director

Has IsoRay been receiving favorable news coverage?

Press coverage about ISR stock has been trending somewhat positive recently, according to Accern. The research firm rates the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. IsoRay earned a news sentiment score of 0.24 on Accern's scale. They also gave news stories about the healthcare company an impact score of 47.10 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of IsoRay?

Shares of ISR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is IsoRay's stock price today?

One share of ISR stock can currently be purchased for approximately $0.5070.

How big of a company is IsoRay?

IsoRay has a market capitalization of $24.87 million.

How can I contact IsoRay?

IsoRay's mailing address is 350 Hills St Ste 106, RICHLAND, WA 99354-5511, United States. The healthcare company can be reached via phone at +1-509-3751202.


MarketBeat Community Rating for IsoRay (ISR)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  80 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  126
MarketBeat's community ratings are surveys of what our community members think about IsoRay and other stocks. Vote "Outperform" if you believe ISR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ISR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

IsoRay (NYSEAMERICAN:ISR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for IsoRay in the last 12 months. Their average twelve-month price target is $1.50, suggesting that the stock has a possible upside of 195.86%. The high price target for ISR is $2.00 and the low price target for ISR is $1.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $1.50$1.50$2.00$3.00
Price Target Upside: 195.86% upside257.14% upside354.55% upside597.67% upside

IsoRay (NYSEAMERICAN:ISR) Consensus Price Target History

Price Target History for IsoRay (NYSEAMERICAN:ISR)

IsoRay (NYSEAMERICAN:ISR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
5/4/2018Maxim GroupSet Price TargetBuy$2.00View Rating Details
4/2/2018Ascendiant Capital MarketsInitiated CoverageBuy$1.00View Rating Details
(Data available from 5/27/2016 forward)

Earnings

IsoRay (NYSEAMERICAN:ISR) Earnings History and Estimates Chart

Earnings by Quarter for IsoRay (NYSEAMERICAN:ISR)

IsoRay (NYSEAMERICAN ISR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2018Q3 2018($0.0250)($0.02)$1.57 millionViewN/AView Earnings Details
2/8/2018After Market($0.02)($0.03)$1.54 millionViewListenView Earnings Details
11/14/2017Q1 2018($0.03)$1.21 millionViewN/AView Earnings Details
9/28/2017Q4 2017($0.01)($0.03)$1.37 millionViewN/AView Earnings Details
5/10/2017Q3 2017($0.02)$1.28 millionViewN/AView Earnings Details
2/8/2017Q2 2017($0.03)$1.03 millionViewN/AView Earnings Details
11/9/2016Q1 2017($0.03)$1.08 millionViewN/AView Earnings Details
9/8/2016Q416($0.02)$1.12 millionViewN/AView Earnings Details
5/10/2016Q316($0.02)$1.16 million$1.20 millionViewN/AView Earnings Details
2/9/2016Q216($0.02)$1.07 million$1.19 millionViewN/AView Earnings Details
11/10/2015Q116($0.01)($0.02)$1.04 million$1.46 millionViewN/AView Earnings Details
9/15/2015Q4($0.01)($0.02)$1.34 millionViewN/AView Earnings Details
5/18/2015Q3($0.01)($0.02)$1.13 million$1.16 millionViewN/AView Earnings Details
2/18/2015Q215($0.02)($0.02)$1.07 millionViewN/AView Earnings Details
9/30/2014Q4 2014($0.03)$0.95 millionViewN/AView Earnings Details
5/16/2014Q314($0.03)($0.05)$1.13 million$1.13 millionViewN/AView Earnings Details
2/18/2014Q2 2014($0.02)$1.09 millionViewN/AView Earnings Details
11/14/2013Q1($0.06)$1.06 million$1.05 millionViewN/AView Earnings Details
9/30/2013Q4 2013($0.03)($0.03)$1.24 millionViewN/AView Earnings Details
5/15/2013Q313($0.03)($0.02)$1.12 million$1.25 millionViewN/AView Earnings Details
2/14/2013Q2 2013($0.03)($0.03)$1.32 million$0.9455 millionViewN/AView Earnings Details
11/14/2012Q113($0.03)($0.03)$1.55 million$1.06 millionViewN/AView Earnings Details
9/28/2012Q4 2012($0.03)($0.03)ViewN/AView Earnings Details
5/15/2012Q3 2012($0.03)($0.03)ViewN/AView Earnings Details
2/15/2012Q2 2012($0.03)ViewN/AView Earnings Details
11/15/2011Q1 2012($0.03)($0.04)ViewN/AView Earnings Details
9/28/2011Q4 2011($0.03)ViewN/AView Earnings Details
5/16/2011Q3 2011($0.03)($0.03)ViewN/AView Earnings Details
2/15/2011Q2 2011($0.04)($0.03)ViewN/AView Earnings Details
11/16/2010Q1 2011($0.05)($0.04)ViewN/AView Earnings Details
9/28/2010Q4 2010($0.05)($0.05)ViewN/AView Earnings Details
5/12/2010Q3 2010($0.04)($0.05)ViewN/AView Earnings Details
2/16/2010Q2 2010($0.03)($0.04)ViewN/AView Earnings Details
11/16/2009Q1 2010($0.05)($0.04)ViewN/AView Earnings Details
9/24/2009Q4 2009($0.04)($0.05)ViewN/AView Earnings Details
5/18/2009Q3 2009($0.06)ViewN/AView Earnings Details
2/17/2009Q2 2009($0.08)($0.07)ViewN/AView Earnings Details
11/13/2008Q1 2009($0.08)($0.08)ViewN/AView Earnings Details
5/13/2008Q3 2008($0.09)ViewN/AView Earnings Details
2/11/2008Q2 2008($0.09)($0.12)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

IsoRay (NYSEAMERICAN:ISR) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

IsoRay (NYSEAMERICAN ISR) Insider Trading and Institutional Ownership History

Insider Trading History for IsoRay (NYSEAMERICAN:ISR)

IsoRay (NYSEAMERICAN ISR) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/14/2018Philip J VitaleDirectorBuy10,000$0.44$4,400.0080,000View SEC Filing  
3/1/2018Thomas C LavoyCEOBuy50,000$0.44$22,000.00View SEC Filing  
11/24/2017Mark John AustinInsiderBuy2,040$0.49$999.602,000View SEC Filing  
11/21/2017Mark John AustinInsiderBuy5,400$0.48$2,592.002,000View SEC Filing  
11/20/2017Michael KrachonVPBuy55,000$0.50$27,500.0019,609View SEC Filing  
11/16/2017Philip J VitaleDirectorBuy30,000$0.44$13,200.00View SEC Filing  
3/10/2017Thomas C LavoyCEOBuy20,000$0.53$10,600.00183,523View SEC Filing  
1/4/2017Philip J VitaleDirectorBuy20,000$0.66$13,200.0037,200View SEC Filing  
12/8/2016Alan HoffmannDirectorBuy20,000$0.57$11,400.00View SEC Filing  
11/17/2016Thomas C LavoyCEOBuy20,000$0.60$12,000.00163,523View SEC Filing  
3/17/2016Thomas C LavoyCEOBuy13,294$0.90$11,964.60143,523View SEC Filing  
3/11/2016Philip J VitaleDirectorBuy10,000$0.93$9,300.0020,000View SEC Filing  
3/11/2016Thomas C LavoyCEOBuy36,706$0.89$32,668.34118,528View SEC Filing  
3/8/2016Michael W MccormickDirectorBuy22,000$0.87$19,140.0022,000View SEC Filing  
11/12/2015Dwight William BabcockCEOBuy25,000$1.27$31,750.00326,402View SEC Filing  
6/9/2015Dwight William BabcockCEOBuy10,000$1.53$15,300.00View SEC Filing  
3/6/2015Thomas C LavoyDirectorBuy10,000$1.66$16,600.00View SEC Filing  
3/5/2015Philip J VitaleDirectorBuy10,000$1.80$18,000.00View SEC Filing  
3/3/2015Dwight William BabcockCEOBuy10,029$1.51$15,143.79View SEC Filing  
11/1/2013Dwight William BabcockCEOBuy25,000$0.53$13,250.00View SEC Filing  
11/28/2012Thomas C LavoyDirectorBuy18,100$0.49$8,869.00View SEC Filing  
11/21/2012Dwight William BabcockCEOBuy10,100$0.40$4,040.00View SEC Filing  
11/19/2012Dwight William BabcockCEOBuy4,800$0.37$1,776.00View SEC Filing  
11/19/2012Robert R KauffmanDirectorBuy25,000$0.38$9,500.00View SEC Filing  
11/16/2012Dwight William BabcockCEOBuy35,100$0.42$14,742.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

IsoRay (NYSEAMERICAN ISR) News Headlines

Source:
DateHeadline
When Will IsoRay Inc (NYSEMKT:ISR) Breakeven?When Will IsoRay Inc (NYSEMKT:ISR) Breakeven?
finance.yahoo.com - May 26 at 9:02 AM
IsoRay (ISR) Short Interest UpdateIsoRay (ISR) Short Interest Update
www.americanbankingnews.com - May 24 at 5:50 PM
Want To Invest In IsoRay Inc (NYSEMKT:ISR)? Here’s How It Performed LatelyWant To Invest In IsoRay Inc (NYSEMKT:ISR)? Here’s How It Performed Lately
finance.yahoo.com - May 17 at 9:27 AM
IsoRay, Inc. Discusses Competitive Landscape, FDA Clearance for New Product Line and Growth Drivers in New SNNLive Video Interview with StockNewsNow.comIsoRay, Inc. Discusses Competitive Landscape, FDA Clearance for New Product Line and Growth Drivers in New SNNLive Video Interview with StockNewsNow.com
finance.yahoo.com - May 17 at 9:27 AM
IsoRay Announces Participation at the American Urological Associations 2018 Annual Meeting, May 18-21, 2018IsoRay Announces Participation at the American Urological Association's 2018 Annual Meeting, May 18-21, 2018
globenewswire.com - May 16 at 9:28 AM
IsoRay Announces Participation at the American Urological Association’s 2018 Annual Meeting, May 18-21, 2018IsoRay Announces Participation at the American Urological Association’s 2018 Annual Meeting, May 18-21, 2018
finance.yahoo.com - May 16 at 9:28 AM
BRIEF-Isoray Announces Disposable Delivery System For Custom Intra-Operative Strands For Prostate Cancer ...BRIEF-Isoray Announces Disposable Delivery System For Custom Intra-Operative Strands For Prostate Cancer ...
www.reuters.com - May 11 at 4:44 PM
IsoRay Announces the First Disposable Delivery System for Custom Intra-operative Strands for Prostate Cancer ...IsoRay Announces the First Disposable Delivery System for Custom Intra-operative Strands for Prostate Cancer ...
globenewswire.com - May 11 at 10:04 AM
IsoRay Announces the First Disposable Delivery System for Custom Intra-operative Strands for Prostate Cancer TreatmentIsoRay Announces the First Disposable Delivery System for Custom Intra-operative Strands for Prostate Cancer Treatment
finance.yahoo.com - May 11 at 10:04 AM
BRIEF-IsoRay Inc Enters A Sales Agreement With HC Wainwright & CoBRIEF-IsoRay Inc Enters A Sales Agreement With HC Wainwright & Co
www.reuters.com - May 9 at 9:18 AM
IsoRay (ISR) PT Set at $2.00 by Maxim GroupIsoRay (ISR) PT Set at $2.00 by Maxim Group
www.americanbankingnews.com - May 4 at 10:33 PM
IsoRay (ISR) Posts  Earnings Results, Meets EstimatesIsoRay (ISR) Posts Earnings Results, Meets Estimates
www.americanbankingnews.com - May 4 at 6:14 PM
BRIEF-Isoray Reports Q3 LOSS PER SHARE $0.02BRIEF-Isoray Reports Q3 LOSS PER SHARE $0.02
www.reuters.com - May 4 at 9:11 AM
IsoRays (ISR) CEO Tom LaVoy on Q3 2018 Results - Earnings Call TranscriptIsoRay's (ISR) CEO Tom LaVoy on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 9:11 AM
IsoRay: Fiscal 3Q Earnings SnapshotIsoRay: Fiscal 3Q Earnings Snapshot
finance.yahoo.com - May 4 at 9:11 AM
IsoRay Announces Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Third Quarter-Over-Third Quarter IncreaseIsoRay Announces Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Third Quarter-Over-Third Quarter Increase
globenewswire.com - May 3 at 4:35 PM
IsoRay Announces Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Third Quarter-Over-Third Quarter IncreaseIsoRay Announces Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Third Quarter-Over-Third Quarter Increase
finance.yahoo.com - May 3 at 4:35 PM
IsoRay to Present at the 3rd Annual Disruptive Growth & Healthcare Conference hosted by RHK CapitalIsoRay to Present at the 3rd Annual Disruptive Growth & Healthcare Conference hosted by RHK Capital
finance.yahoo.com - May 2 at 9:12 AM
IsoRay Announces Third Quarter Fiscal 2018 Earnings Conference CallIsoRay Announces Third Quarter Fiscal 2018 Earnings Conference Call
finance.yahoo.com - April 26 at 9:05 AM
IsoRay to Present at the Planet MicroCap Showcase 2018 on April 25 in Las Vegas, NVIsoRay to Present at the Planet MicroCap Showcase 2018 on April 25 in Las Vegas, NV
finance.yahoo.com - April 19 at 9:12 AM
IsoRay Announces Preliminary Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Year-over-Year IncreaseIsoRay Announces Preliminary Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Year-over-Year Increase
finance.yahoo.com - April 18 at 9:17 AM
IsoRay (ISR) Coverage Initiated at Ascendiant Capital MarketsIsoRay (ISR) Coverage Initiated at Ascendiant Capital Markets
www.americanbankingnews.com - April 2 at 2:38 PM
Benzingas Top Upgrades, Downgrades For April 2, 2018Benzinga's Top Upgrades, Downgrades For April 2, 2018
www.benzinga.com - April 2 at 9:44 AM
Pivotal Research Starts IsoRay, Inc. (ISR) at Buy Citing ValuationPivotal Research Starts IsoRay, Inc. (ISR) at Buy Citing Valuation
www.streetinsider.com - April 2 at 9:44 AM
UPDATE: Ascendiant Starts IsoRay, Inc. (ISR) at Buy Citing ValuationUPDATE: Ascendiant Starts IsoRay, Inc. (ISR) at Buy Citing Valuation
www.streetinsider.com - April 2 at 9:44 AM
IsoRay, Inc. (ISR) CEO Thomas C. Lavoy Acquires 50,000 SharesIsoRay, Inc. (ISR) CEO Thomas C. Lavoy Acquires 50,000 Shares
www.americanbankingnews.com - March 2 at 7:34 PM
IsoRay (ISR) Given a $2.00 Price Target at Maxim GroupIsoRay (ISR) Given a $2.00 Price Target at Maxim Group
www.americanbankingnews.com - February 14 at 10:40 PM
IsoRay (ISR) Announces  Earnings ResultsIsoRay (ISR) Announces Earnings Results
www.americanbankingnews.com - February 10 at 11:44 AM
IsoRay, Inc. (ISR) Sees Large Drop in Short InterestIsoRay, Inc. (ISR) Sees Large Drop in Short Interest
www.americanbankingnews.com - February 9 at 6:56 PM
IsoRay Announces Second Quarter Fiscal 2018 Revenue of $1.54 Million, 50% Second Quarter-Over-Second Quarter IncreaseIsoRay Announces Second Quarter Fiscal 2018 Revenue of $1.54 Million, 50% Second Quarter-Over-Second Quarter Increase
finance.yahoo.com - February 8 at 4:16 PM
IsoRay (ISR) PT Set at $3.00 by Maxim GroupIsoRay (ISR) PT Set at $3.00 by Maxim Group
www.americanbankingnews.com - February 8 at 3:18 PM
IsoRay Announces Study Published in Cureus entitled, “Resection Cavity Contraction Effects in the Use of Radioactive Sources (1-25 versus Cs‑131) for Intra-Operative Brain Implants”IsoRay Announces Study Published in Cureus entitled, “Resection Cavity Contraction Effects in the Use of Radioactive Sources (1-25 versus Cs‑131) for Intra-Operative Brain Implants”
finance.yahoo.com - February 8 at 8:48 AM
Was IsoRay Inc’s (NYSEMKT:ISR) Earnings Decline A Part Of Broader Industry Downturn?Was IsoRay Inc’s (NYSEMKT:ISR) Earnings Decline A Part Of Broader Industry Downturn?
finance.yahoo.com - February 6 at 9:15 AM
IsoRay Announces Second Quarter Fiscal 2018 Earnings Conference CallIsoRay Announces Second Quarter Fiscal 2018 Earnings Conference Call
finance.yahoo.com - January 31 at 9:36 AM
IsoRay (ISR) to Release Quarterly Earnings on TuesdayIsoRay (ISR) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - January 30 at 3:46 AM
IsoRay (ISR) Given a $3.00 Price Target by Maxim Group AnalystsIsoRay (ISR) Given a $3.00 Price Target by Maxim Group Analysts
www.americanbankingnews.com - January 24 at 2:02 PM
IsoRay Announces Preliminary Second Quarter F2018 Revenue of $1.54 Million, 50% Year-over-Year IncreaseIsoRay Announces Preliminary Second Quarter F2018 Revenue of $1.54 Million, 50% Year-over-Year Increase
finance.yahoo.com - January 24 at 9:47 AM
IsoRay Announces Case Report Publication Discussing Focal Radiation Treatment of Brain Metastases with Cesium-131IsoRay Announces Case Report Publication Discussing Focal Radiation Treatment of Brain Metastases with Cesium-131
finance.yahoo.com - January 9 at 10:29 AM
IsoRay Announces Manufacturing and Supply Agreement with GT Medical Technologies for GammaTile™ Radiation Therapy SystemIsoRay Announces Manufacturing and Supply Agreement with GT Medical Technologies for GammaTile™ Radiation Therapy System
finance.yahoo.com - January 8 at 11:05 AM
ETFs with exposure to IsoRay, Inc. : December 26, 2017ETFs with exposure to IsoRay, Inc. : December 26, 2017
finance.yahoo.com - December 26 at 12:49 PM
ETFs with exposure to IsoRay, Inc. : December 7, 2017ETFs with exposure to IsoRay, Inc. : December 7, 2017
finance.yahoo.com - December 7 at 3:31 PM
IsoRay, Inc. :ISR-US: Earnings Analysis: Q1, 2018 By the Numbers : December 1, 2017IsoRay, Inc. :ISR-US: Earnings Analysis: Q1, 2018 By the Numbers : December 1, 2017
finance.yahoo.com - December 1 at 11:57 AM
IsoRay to Present at the 10th Annual LD Micro Main EventIsoRay to Present at the 10th Annual LD Micro Main Event
finance.yahoo.com - November 28 at 9:46 AM
IsoRay, Inc. (ISR) VP Buys $27,500.00 in StockIsoRay, Inc. (ISR) VP Buys $27,500.00 in Stock
www.americanbankingnews.com - November 21 at 4:41 PM
Maxim Group Reiterates "$3.00" Price Target for IsoRay, Inc. (ISR)Maxim Group Reiterates "$3.00" Price Target for IsoRay, Inc. (ISR)
www.americanbankingnews.com - November 19 at 5:38 PM
Philip J. Vitale Acquires 30,000 Shares of IsoRay, Inc. (ISR) StockPhilip J. Vitale Acquires 30,000 Shares of IsoRay, Inc. (ISR) Stock
www.americanbankingnews.com - November 17 at 9:50 PM
IsoRay reports 1Q lossIsoRay reports 1Q loss
finance.yahoo.com - November 17 at 8:18 AM
IsoRay, Inc. (ISR) Issues  Earnings ResultsIsoRay, Inc. (ISR) Issues Earnings Results
www.americanbankingnews.com - November 15 at 12:56 PM
IsoRay Announces First Quarter Fiscal 2018 Financial Results - GlobeNewswire (press release)IsoRay Announces First Quarter Fiscal 2018 Financial Results - GlobeNewswire (press release)
globenewswire.com - November 15 at 3:21 AM
IsoRay, Inc. to Host Earnings CallIsoRay, Inc. to Host Earnings Call
finance.yahoo.com - November 15 at 3:21 AM

SEC Filings

IsoRay (NYSEAMERICAN:ISR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

IsoRay (NYSEAMERICAN:ISR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

IsoRay (NYSEAMERICAN ISR) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.